Circulation Journal

Papers
(The H4-Index of Circulation Journal is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease193
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure104
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias92
JCS/JACR 2021 Guideline on Rehabilitation in Patients With Cardiovascular Disease86
Clinical Characteristics and Outcomes of Hospitalized Patients With Heart Failure From the Large-Scale Japanese Registry Of Acute Decompensated Heart Failure (JROADHF)70
JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction68
Intravascular Lithotripsy for Vessel Preparation in Severely Calcified Coronary Arteries Prior to Stent Placement　― Primary Outcomes From the Japanese Disrupt CAD IV Study ―64
Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease　― Japanese Guideline on the Management of Asymptomatic Hyperuricemia ―62
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies56
JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases56
Pathophysiology of Coronary Microvascular Dysfunction55
JCS 2022 Guideline Focused Update on Diagnosis and Treatment in Patients With Stable Coronary Artery Disease55
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias54
Impact of the COVID-19 Pandemic on Door-to-Balloon Time for Primary Percutaneous Coronary Intervention　― Results From the Singapore Western STEMI Network ―51
JCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease46
Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction　― Results From the PARALLEL-HF Study ―43
Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention　― From the CREDO-Kyoto Registry Cohort-3 ―37
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury34
JCS/JSCVS/JATS/JSVS 2020 Guideline on Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection31
One-Year Outcome After Percutaneous Coronary Intervention for Acute Coronary Syndrome　― An Analysis of 20,042 Patients From a Japanese Nationwide Registry ―31
Novel Cryoballoon Ablation System for Single Shot Pulmonary Vein Isolation　― The Prospective ICE-AGE-X Study ―30
Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan29
Barthel Index Score Predicts Mortality in Elderly Heart Failure　― A Goal of Comprehensive Cardiac Rehabilitation ―28
Evaluation of the Accuracy of ChatGPT in Answering Clinical Questions on the Japanese Society of Hypertension Guidelines27
Current Understanding of the Role of Frailty in Cardiovascular Disease26
Effect of Cumulative Exposure to Low-Density Lipoprotein-Cholesterol on Cardiovascular Events in Patients With Familial Hypercholesterolemia26
JCS 2021 Guideline on the Clinical Application of Echocardiography26
0.022748947143555